AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,147 | -3.4% | 137 | +18.1% | 0.00% | – |
| Q4 2022 | $3,257 | – | 116 | +11500.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1 | -99.5% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | 0.0% | 193 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | +200.0% | 193 | +338.6% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 44 | +120.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 20 | +11.1% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 18 | -45.5% | 0.00% | -100.0% |
| Q2 2020 | $2,000 | +100.0% | 33 | +106.2% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 16 | +23.1% | 0.00% | – |
| Q1 2019 | $1,000 | – | 13 | +1200.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 1 | -85.7% | 0.00% | – |
| Q2 2018 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |